Skip Navigation U.S. Department of Health and Human Services
Agency for Healthcare Research Quality
Archive print banner

Slide Presentation of the 2007 Annual Meeting of AHRQ

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to for current information.

The Perils of EBM

Text Description is below the image.
  • Potential for unintended consequences
    • Justifies coverage decisions based purely on cost without regard for overall effectiveness or value
    • Freezes the pace of innovation to the current generation of products
    • Discriminates against new technologies
    • Leads to prescriptive clinical protocols that do not allow for physician judgment and consideration of patient preferences
    • Focuses too narrowly on clinical morbidity or mortality, ignoring a range of other important patient-reported outcomes (ease of use, compliance, functional status)
    • Changes to coverage policies occur haphazardly without clear rationale, transparency or accountability

Previous Slide Previous Slide         Contents         Next Slide Next Slide


The information on this page is archived and provided for reference purposes only.


AHRQ Advancing Excellence in Health Care